Refresher Course: Neuro

RC 711 - Anti-amyloid antibody treatment in Alzheimer's disease

February 27, 08:15 - 09:15 CET

5 min
Chairperson's introduction
15 min
Amyloid-related imaging abnormalities (ARIA): findings and mechanism
  1. To describe the concept and pathophysiology of ARIA.
  2. To review the significance of ARIA related to the newly developed drugs for Alzheimer's disease.
  3. To discuss the clinical significance of ARIA.
15 min
Bringing amyloid-treatment monitoring into daily clinical practice
  1. To understand the clinical significance of ARIA and the need for imaging monitoring.
  2. To discuss the MR imaging protocol for the monitoring of ARIA.
  3. To discuss the current guidelines in the novel treatments, relevant to the radiologist.
15 min
The role of PET in Alzheimer's disease and anti-amyloid treatment
  1. To discuss the role of PET in the diagnosis of Alzheimer's disease.
  2. To review the role of PET in the follow-up of patients on anti-amyloid treatment.
  3. To highlight the complementary role of MRI and PET.
10 min
Panel discussion: Anti-amyloid antibody treatment in Alzheimer's disease, a new horizon?